tiprankstipranks
Pacira Pharmaceuticals (PCRX)
NASDAQ:PCRX
US Market
PCRX
Pacira Pharmaceuticals
RESEARCH TOOLSreports

Pacira Pharmaceuticals (PCRX) Income Statement

383 Followers

Pacira Pharmaceuticals Income Statement

Last quarter (Q4 2025), Pacira Pharmaceuticals's total revenue was $196.87M, an increase of 5.14% from the same quarter last year. In Q4, Pacira Pharmaceuticals's net income was $1.64M. See Pacira Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 726.41M$ 700.97M$ 674.98M$ 666.82M$ 541.53M
Gross Profit
$ 519.37M$ 530.54M$ 490.31M$ 467.53M$ 401.28M
Operating Expenses
$ 491.27M$ 603.91M$ 402.63M$ 407.50M$ 311.35M
Depreciation and Amortization
$ 91.02M$ 78.78M$ 75.57M$ 91.50M$ 28.55M
EBITDA
$ 119.13M$ 29.12M$ 154.59M$ 140.38M$ 113.95M
Operating Income
$ 28.10M$ -73.37M$ 87.67M$ 60.02M$ 89.92M
Other Income/Expenses
$ -11.23M$ 10.27M$ -25.97M$ -46.72M$ -33.52M
Pretax Income
$ 16.87M$ -63.11M$ 61.70M$ 13.30M$ 56.40M
Net Income
$ 7.03M$ -99.56M$ 41.95M$ 15.91M$ 41.98M
Per Share Metrics
Basic EPS
$ 0.16$ -2.15$ 0.91$ 0.35$ 0.95
Diluted EPS
$ 0.16$ -2.15$ 0.89$ 0.34$ 0.92
Weighted Average Shares Outstanding
 44.57M 46.24M 46.22M 45.52M 44.26M
Weighted Average Shares Outstanding (Diluted)
 45.04M 46.24M 51.98M 46.54M 45.63M
Currency in USD

Pacira Pharmaceuticals Earnings and Revenue History